158 related articles for article (PubMed ID: 33455103)
1. Therapeutic effect of thalidomide combined with temozolomide and three-dimensional conformal radiotherapy for patients with high-grade gliomas after operation.
Sui L; Li Y; Xu Z; Shen X
J BUON; 2020; 25(6):2608-2615. PubMed ID: 33455103
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of thalidomide combined with temozolomide and three-dimensional conformal radiotherapy for patients with high-grade gliomas after operation.
Sui L; Li Y; Xu Z; Shen X
J BUON; 2021; 26(1):2608-2615. PubMed ID: 33721435
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide chemotherapy combined with radiotherapy versus radiotherapy alone after surgery in patients with high-risk low-grade gliomas.
Hou Y; Huan Y; Zhang Y; Liu X; Li Y
J BUON; 2021; 26(3):977-983. PubMed ID: 34268962
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of bevacizumab combined with temozolomide dose-dense regimen on recurrent glioma.
Li J; Huang W; Piao M; Liu Z; Ji S; Xue J; Zhu X
J BUON; 2021; 26(1):145-151. PubMed ID: 33721445
[TBL] [Abstract][Full Text] [Related]
5. Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study.
Wang J; Yan L; Ai P; He Y; Guan H; Wei Z; He L; Mu X; Liu Y; Peng X
Neurosurg Rev; 2021 Jun; 44(3):1447-1455. PubMed ID: 32529528
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
7. Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis.
Wang J; Huang Y; Zhao F; Chen J; He L; Liu Z; Pei Y; Wei Z; Li R; Ai P; Peng X
J Neurooncol; 2022 Nov; 160(2):433-443. PubMed ID: 36357822
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of synchronous stereotactic radiotherapy with temozolomide combined with whole brain radiotherapy in treating brain metastases originating from non-small cell lung cancer.
Liu P; Ren R; You D; Liu J
J BUON; 2020; 25(4):1771-1778. PubMed ID: 33099912
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of 3-dimensional conformal radiotherapy combined with temozolomide for glioma].
Wang L; Tu Q; Zhou W; Zhou R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1106-10. PubMed ID: 22169729
[TBL] [Abstract][Full Text] [Related]
10. Surgery, radiotherapy and temozolomide in treating high-grade gliomas.
Parlato C; Barbarisi M; Moraci M; Moraci A
Front Biosci; 2006 May; 11():1280-3. PubMed ID: 16368514
[TBL] [Abstract][Full Text] [Related]
11. Comparison of carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high-grade gliomas: explorative hypothesis-generating retrospective analysis.
Combs SE; Bruckner T; Mizoe JE; Kamada T; Tsujii H; Kieser M; Debus J
Radiother Oncol; 2013 Jul; 108(1):132-5. PubMed ID: 23932193
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of transcatheter arterial chemoembolization combined with 125I seed implantation and three-dimensional conformal radiotherapy in advanced primary hepatocellular carcinoma.
Zhang H; Yang A; Zhang J
J BUON; 2020; 25(2):952-958. PubMed ID: 32521891
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.
Fine HA; Figg WD; Jaeckle K; Wen PY; Kyritsis AP; Loeffler JS; Levin VA; Black PM; Kaplan R; Pluda JM; Yung WK
J Clin Oncol; 2000 Feb; 18(4):708-15. PubMed ID: 10673511
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial.
Wang J; Wang Y; He Y; Guan H; He L; Mu X; Peng X
Trials; 2019 Nov; 20(1):641. PubMed ID: 31752981
[TBL] [Abstract][Full Text] [Related]
15. Particle radiation therapy in the management of malignant glioma: Early experience at the Shanghai Proton and Heavy Ion Center.
Kong L; Wu J; Gao J; Qiu X; Yang J; Hu J; Hu W; Mao Y; Lu JJ
Cancer; 2020 Jun; 126(12):2802-2810. PubMed ID: 32167589
[TBL] [Abstract][Full Text] [Related]
16. A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.
Steidl E; Filipski K; Zeiner PS; Wagner M; Fokas E; Forster MT; Ronellenfitsch MW; Divé I; Steinbach JP; Harter PN; Bähr O
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2373-2383. PubMed ID: 33538917
[TBL] [Abstract][Full Text] [Related]
17. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
18. Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.
Dworkin M; Mehan W; Niemierko A; Kamran SC; Lamba N; Dietrich J; Martinez-Lage M; Oh KS; Batchelor TT; Wen PY; Loeffler JS; Shih HA
J Neurooncol; 2019 Mar; 142(1):69-77. PubMed ID: 30488294
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide and radiotherapy versus radiotherapy alone in high grade gliomas: a very long term comparative study and literature review.
Parisi S; Corsa P; Raguso A; Perrone A; Cossa S; Munafò T; Sanpaolo G; Donno E; Clemente MA; Piombino M; Parisi F; Valle G
Biomed Res Int; 2015; 2015():620643. PubMed ID: 25815327
[TBL] [Abstract][Full Text] [Related]
20. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
